JIN MEDICAL INTERNATIONAL

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZJYL and other ETFs, options, and stocks.

About ZJYL

Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture, and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China. 

CEO
Er Qi Wang
CEOEr Qi Wang
Employees
269
Employees269
Headquarters
Changzhou, Jiangsu
HeadquartersChangzhou, Jiangsu
Founded
2020
Founded2020
Employees
269
Employees269

ZJYL Key Statistics

Market cap
28.98M
Market cap28.98M
Price-Earnings ratio
21.68
Price-Earnings ratio21.68
Dividend yield
Dividend yield
Average volume
209.30K
Average volume209.30K
High today
$0.255
High today$0.255
Low today
$0.1619
Low today$0.1619
Open price
$0.2461
Open price$0.2461
Volume
1.13M
Volume1.13M
52 Week high
$1.12
52 Week high$1.12
52 Week low
$0.1619
52 Week low$0.1619

Stock Snapshot

With a market cap of 28.98M, JIN MEDICAL INTERNATIONAL(ZJYL) trades at $0.19. The stock has a price-to-earnings ratio of 21.68.

On 2026-01-14, JIN MEDICAL INTERNATIONAL(ZJYL) stock moved within a range of $0.16 to $0.26. With shares now at $0.19, the stock is trading +14.3% above its intraday low and -27.4% below the session's peak.

Trading volume for JIN MEDICAL INTERNATIONAL(ZJYL) stock has reached 1.13M, versus its average volume of 209.3K.

The stock's 52-week range extends from a low of $0.16 to a high of $1.12.

The stock's 52-week range extends from a low of $0.16 to a high of $1.12.

People also own

Based on the portfolios of people who own ZJYL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .